Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 24 studies | 34% ± 15% | |
| astrocyte | 17 studies | 40% ± 18% | |
| oligodendrocyte precursor cell | 12 studies | 42% ± 18% | |
| macrophage | 12 studies | 37% ± 16% | |
| microglial cell | 12 studies | 41% ± 13% | |
| oligodendrocyte | 12 studies | 41% ± 15% | |
| fibroblast | 11 studies | 31% ± 13% | |
| pericyte | 10 studies | 32% ± 15% | |
| GABAergic neuron | 9 studies | 37% ± 18% | |
| adipocyte | 9 studies | 33% ± 9% | |
| smooth muscle cell | 9 studies | 27% ± 9% | |
| epithelial cell | 8 studies | 38% ± 18% | |
| T cell | 8 studies | 24% ± 8% | |
| CD4-positive, alpha-beta T cell | 7 studies | 21% ± 5% | |
| plasmacytoid dendritic cell | 7 studies | 22% ± 6% | |
| dendritic cell | 7 studies | 33% ± 11% | |
| mast cell | 7 studies | 26% ± 8% | |
| glutamatergic neuron | 6 studies | 48% ± 22% | |
| interneuron | 6 studies | 43% ± 18% | |
| myeloid cell | 6 studies | 26% ± 6% | |
| ciliated cell | 6 studies | 26% ± 9% | |
| monocyte | 6 studies | 32% ± 8% | |
| endothelial cell of lymphatic vessel | 6 studies | 34% ± 13% | |
| neuron | 5 studies | 51% ± 20% | |
| B cell | 5 studies | 26% ± 9% | |
| CD8-positive, alpha-beta T cell | 5 studies | 21% ± 4% | |
| cardiac muscle cell | 5 studies | 36% ± 9% | |
| retinal cone cell | 5 studies | 28% ± 10% | |
| natural killer cell | 5 studies | 27% ± 8% | |
| club cell | 5 studies | 31% ± 12% | |
| type I pneumocyte | 5 studies | 33% ± 9% | |
| type II pneumocyte | 5 studies | 29% ± 7% | |
| basal cell | 5 studies | 34% ± 21% | |
| granule cell | 4 studies | 28% ± 8% | |
| mesothelial cell | 4 studies | 28% ± 9% | |
| lymphocyte | 4 studies | 39% ± 20% | |
| Mueller cell | 4 studies | 37% ± 16% | |
| amacrine cell | 4 studies | 36% ± 10% | |
| retina horizontal cell | 4 studies | 35% ± 14% | |
| retinal rod cell | 4 studies | 39% ± 8% | |
| regulatory T cell | 4 studies | 19% ± 4% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 21% ± 6% | |
| glial cell | 3 studies | 29% ± 10% | |
| progenitor cell | 3 studies | 39% ± 10% | |
| plasma cell | 3 studies | 33% ± 4% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 23% ± 4% | |
| vein endothelial cell | 3 studies | 35% ± 20% | |
| GABAergic amacrine cell | 3 studies | 35% ± 12% | |
| glycinergic amacrine cell | 3 studies | 36% ± 10% | |
| endothelial cell of vascular tree | 3 studies | 36% ± 20% | |
| hepatocyte | 3 studies | 39% ± 13% | |
| retinal pigment epithelial cell | 3 studies | 39% ± 21% | |
| abnormal cell | 3 studies | 33% ± 22% | |
| ependymal cell | 3 studies | 46% ± 16% | |
| alveolar macrophage | 3 studies | 35% ± 10% | |
| capillary endothelial cell | 3 studies | 25% ± 6% | |
| respiratory goblet cell | 3 studies | 35% ± 11% | |
| goblet cell | 3 studies | 41% ± 30% | |
| leukocyte | 3 studies | 47% ± 8% | |
| transit amplifying cell | 3 studies | 41% ± 32% | |
| mural cell | 3 studies | 39% ± 13% | |
| mucus secreting cell | 3 studies | 29% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2142.10 | 1445 / 1445 | 100% | 16.55 | 183 / 183 |
| prostate | 100% | 2117.63 | 245 / 245 | 100% | 11.08 | 502 / 502 |
| uterus | 100% | 2321.12 | 170 / 170 | 100% | 10.39 | 458 / 459 |
| lung | 100% | 2273.60 | 578 / 578 | 100% | 10.75 | 1152 / 1155 |
| breast | 100% | 2144.76 | 459 / 459 | 100% | 17.43 | 1115 / 1118 |
| thymus | 100% | 2290.26 | 653 / 653 | 100% | 10.65 | 603 / 605 |
| ovary | 100% | 2369.98 | 180 / 180 | 100% | 12.37 | 428 / 430 |
| intestine | 100% | 2024.69 | 966 / 966 | 99% | 8.93 | 524 / 527 |
| bladder | 100% | 2067.95 | 21 / 21 | 99% | 8.92 | 500 / 504 |
| pancreas | 100% | 1203.92 | 328 / 328 | 99% | 8.42 | 176 / 178 |
| brain | 99% | 1064.68 | 2608 / 2642 | 100% | 9.92 | 705 / 705 |
| stomach | 100% | 1532.13 | 359 / 359 | 99% | 11.45 | 282 / 286 |
| kidney | 100% | 1259.37 | 89 / 89 | 98% | 9.49 | 885 / 901 |
| adrenal gland | 100% | 1605.29 | 258 / 258 | 98% | 6.50 | 225 / 230 |
| skin | 100% | 2560.70 | 1809 / 1809 | 96% | 8.58 | 451 / 472 |
| liver | 100% | 742.22 | 225 / 226 | 73% | 3.53 | 298 / 406 |
| adipose | 100% | 1891.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 2041.29 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 6.19 | 29 / 29 |
| spleen | 100% | 1833.56 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 12.50 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.65 | 1 / 1 |
| muscle | 100% | 1157.70 | 801 / 803 | 0% | 0 | 0 / 0 |
| heart | 98% | 1127.64 | 845 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 89% | 1145.24 | 825 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 85% | 4.86 | 68 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0008285 | Biological process | negative regulation of cell population proliferation |
| GO_0030071 | Biological process | regulation of mitotic metaphase/anaphase transition |
| GO_0048568 | Biological process | embryonic organ development |
| GO_0045582 | Biological process | positive regulation of T cell differentiation |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
| GO_0045663 | Biological process | positive regulation of myoblast differentiation |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0060038 | Biological process | cardiac muscle cell proliferation |
| GO_0070316 | Biological process | regulation of G0 to G1 transition |
| GO_0045597 | Biological process | positive regulation of cell differentiation |
| GO_1905168 | Biological process | positive regulation of double-strand break repair via homologous recombination |
| GO_2000819 | Biological process | regulation of nucleotide-excision repair |
| GO_0060982 | Biological process | coronary artery morphogenesis |
| GO_0042592 | Biological process | homeostatic process |
| GO_0030336 | Biological process | negative regulation of cell migration |
| GO_0006337 | Biological process | nucleosome disassembly |
| GO_2000781 | Biological process | positive regulation of double-strand break repair |
| GO_0003007 | Biological process | heart morphogenesis |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0000776 | Cellular component | kinetochore |
| GO_0016514 | Cellular component | SWI/SNF complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016363 | Cellular component | nuclear matrix |
| GO_0016586 | Cellular component | RSC-type complex |
| GO_0000785 | Cellular component | chromatin |
| GO_0003677 | Molecular function | DNA binding |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARID2 |
| Protein name | AT rich interactive domain 2 (ARID, RFX-like), isoform CRA_d (AT-rich interaction domain 2) ARID2 protein AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200) AT-rich interaction domain 2 |
| Synonyms | KIAA1557 BAF200 hCG_1998145 |
| Description | FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). May be involved in targeting the complex to different genes. May be involved in regulating transcriptional activation of cardiac genes. . |
| Accessions | ENST00000479608.5 F8WCU9 F8VWP4 Q4G0S8 Q8WV72 ENST00000444670.5 ENST00000422737.7 A0A087WY37 ENST00000477947.1 A0A8V8TP93 ENST00000457135.2 Q68CP9 F8W108 ENST00000334344.11 [Q68CP9-1] |